Literature DB >> 18057890

Impaired exercise capacity in diabetic patients after coronary bypass surgery: effects of diastolic and endothelial function.

Yen-Wen Wu1, Ching-Ling Hsu, Shoei-Shen Wang, Mei-Wun Tsai, Shu-Hsiun Chu, Yih-Sharng Chen, Wei-Shiung Yang, Ying-Tai Wu.   

Abstract

OBJECTIVES: The aims of this study were to clarify the influence of cardiac diastolic and peripheral vascular function on the exercise capacity of patients with coronary bypass surgery (CABG) and diabetes mellitus (DM) by tissue Doppler imaging (TDI) and flow-mediated vasodilatation (FMD), and to investigate interrelations between exercise capacity and LV diastolic function, endothelial function and biochemical parameters.
METHODS: We analyzed the exercise capacity, TDI at the mitral annulus and FMD in 51 uncomplicated first-time CABG survivors (23 DM) at an average interval of 21.6 +/- 12.2 months after surgery.
RESULTS: Diabetics had lower E', A', VO(2)peak, (a-v)O(2) difference, and higher E/E' ratios (p < 0.05) than non-DM patients, but not FMD (p = 0.17). The A and E/E' ratios correlated negatively with VO(2)peak after age adjustment (r = -0.336, p = 0.024). In addition, HbA(1c), and triglyceride also correlated negatively with VO(2)peak (r = -0.377, -0.307, respectively, p < 0.05).
CONCLUSIONS: Diabetics after CABG had more advanced diastolic dysfunction and oxygen extraction impairment than non-DM. It suggests these factors could contribute to lower exercise capacity, risk of developing heart failure despite preserved systolic function and poorer long-term survival of diabetic patients after CABG. (c) 2007 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2007        PMID: 18057890     DOI: 10.1159/000111929

Source DB:  PubMed          Journal:  Cardiology        ISSN: 0008-6312            Impact factor:   1.869


  6 in total

1.  Cardiovascular phenotype in HFpEF patients with or without diabetes: a RELAX trial ancillary study.

Authors:  Brian R Lindman; Victor G Dávila-Román; Douglas L Mann; Steven McNulty; Marc J Semigran; Gregory D Lewis; Lisa de las Fuentes; Susan M Joseph; Justin Vader; Adrian F Hernandez; Margaret M Redfield
Journal:  J Am Coll Cardiol       Date:  2014-08-12       Impact factor: 24.094

2.  Effect of intrathecal midazolam in the severity of pain in cesarean section: a randomized controlled trail.

Authors:  A Karbasfrushan; K Farhadi; J Amini-Saman; S Bazargan-Hejazi; A Ahmadi
Journal:  Iran Red Crescent Med J       Date:  2012-05-30       Impact factor: 0.611

Review 3.  Advanced glycation end-products, a pathophysiological pathway in the cardiorenal syndrome.

Authors:  Suzan Willemsen; Jasper W L Hartog; M Rebecca Heiner-Fokkema; Dirk J van Veldhuisen; Adriaan A Voors
Journal:  Heart Fail Rev       Date:  2012-03       Impact factor: 4.214

Review 4.  Exercise Intolerance in Older Adults With Heart Failure With Preserved Ejection Fraction: JACC State-of-the-Art Review.

Authors:  Ambarish Pandey; Sanjiv J Shah; Javed Butler; Dean L Kellogg; Gregory D Lewis; Daniel E Forman; Robert J Mentz; Barry A Borlaug; Marc A Simon; Julio A Chirinos; Roger A Fielding; Elena Volpi; Anthony J A Molina; Mark J Haykowsky; Flora Sam; Bret H Goodpaster; Alain G Bertoni; Jamie N Justice; James P White; Jingzhone Ding; Scott L Hummel; Nathan K LeBrasseur; George E Taffet; Iraklis I Pipinos; Dalane Kitzman
Journal:  J Am Coll Cardiol       Date:  2021-09-14       Impact factor: 27.203

5.  Mechanical dyssynchrony and diastolic dysfunction are common in LVH: a pilot correlation study using Doppler echocardiography and CZT gated-SPECT MPI.

Authors:  Szu-Ying Tsai; Shan-Ying Wang; Yu-Chien Shiau; Yen-Wen Wu
Journal:  Sci Rep       Date:  2018-03-08       Impact factor: 4.379

6.  Continuous, non-invasive measurement of the haemodynamic response to submaximal exercise in patients with diabetes mellitus: evidence of impaired cardiac reserve and peripheral vascular response.

Authors:  D Joshi; A Shiwalkar; M R Cross; S K Sharma; A Vachhani; C Dutt
Journal:  Heart       Date:  2009-10-22       Impact factor: 5.994

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.